Published in Am J Med on September 01, 1991
A "hot" topic in dyslipidemia management--"how to beat a flush": optimizing niacin tolerability to promote long-term treatment adherence and coronary disease prevention. Mayo Clin Proc (2010) 0.91
Evaluation of efficacy and safety of fixed dose lovastatin and niacin(ER) combination in asian Indian dyslipidemic patients: a multicentric study. Vasc Health Risk Manag (2006) 0.79
Raising HDL cholesterol with low-dose nicotinic acid and bezafibrate: preliminary experience. Postgrad Med J (1993) 0.75
Familial combined hyperlipoproteinemia. CMAJ (1992) 0.75
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 10.99
Human erythrocyte membrane glycoprotein: a re-evaluation of the molecular weight as determined by SDS polyacrylamide gel electrophoresis. Biochem Biophys Res Commun (1971) 5.18
Associations of race/ethnicity, education, and dietary intervention with the validity and reliability of a food frequency questionnaire: the Women's Health Trial Feasibility Study in Minority Populations. Am J Epidemiol (1997) 3.57
A molecular theory of lipid-protein interactions in the plasma lipoproteins. FEBS Lett (1974) 3.43
Chemical characterization and surface orientation of the major glycoprotein of the human erythrocyte membrane. Proc Natl Acad Sci U S A (1972) 3.27
Perilipins, ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cells. Semin Cell Dev Biol (1999) 3.01
Comparison of two methods of assessing physical activity in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol (1991) 2.96
Membrane proteins: amino acid sequence and membrane penetration. J Mol Biol (1974) 2.67
Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J Lipid Res (1980) 2.63
Effect of antihypertensives on sexual function and quality of life: the TAIM Study. Ann Intern Med (1991) 2.49
Major glycoprotein of the human erythrocyte membrane: evidence for an amphipathic molecular structure. Arch Biochem Biophys (1973) 2.44
NHLBI family blood pressure program: methodology and recruitment in the HyperGEN network. Hypertension genetic epidemiology network. Ann Epidemiol (2000) 2.28
Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group. Arch Intern Med (1993) 2.26
Issues in the natural history and treatment of coronary heart disease in black populations: surgical treatment. Am Heart J (1984) 2.18
Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide. J Lipid Res (2001) 2.11
Symptom-limited graded treadmill exercise testing in young adults in the CARDIA study. Med Sci Sports Exerc (1992) 1.99
Impact of hypertension information on high blood pressure control between 1973 and 1978. Hypertension (1980) 1.98
Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine. J Biol Chem (1985) 1.89
An amphipathic alpha-helix at a membrane interface: a structural study using a novel X-ray diffraction method. J Mol Biol (1999) 1.82
Red cell membrane glycoprotein: amino acid sequence of an intramembranous region. Biochem Biophys Res Commun (1972) 1.80
Natural history of angina pectoris. Am J Cardiol (1974) 1.79
Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation (2001) 1.69
Association of the membrane-penetrating polypeptide segment of the human erythrocyte MN-glycoprotein with phospholipid bilayers. I. Formation of freeze-etch intramembranous particles. Proc Natl Acad Sci U S A (1974) 1.66
The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial. Diabetologia (2006) 1.65
Mean field stochastic boundary molecular dynamics simulation of a phospholipid in a membrane. Biochemistry (1991) 1.60
Regional disparities in the incidence of elevated blood pressure among young adults: the CARDIA study. Circulation (1997) 1.58
Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity. Implications for HDL assembly. Arterioscler Thromb Vasc Biol (1996) 1.55
Computer programs to identify and classify amphipathic alpha helical domains. J Lipid Res (1992) 1.54
Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein. J Biol Chem (1992) 1.53
A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis. J Lipid Res (2001) 1.53
Effect of oxidation on the properties of apolipoproteins A-I and A-II. J Lipid Res (1988) 1.52
Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery. The Coronary Artery Surgery Study (CASS) Circulation (1990) 1.51
Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. Hypertension (1998) 1.51
Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins. J Biol Chem (1993) 1.50
Mechanisms for the modulation of membrane bilayer properties by amphipathic helical peptides. Biopolymers (1995) 1.48
The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life. Am J Hypertens (1992) 1.43
Effect of bypass surgery on survival in patients in low- and high-risk subgroups delineated by the use of simple clinical variables. Circulation (1981) 1.42
Interactions of synthetic peptide analogs of the class A amphipathic helix with lipids. Evidence for the snorkel hypothesis. J Biol Chem (1994) 1.39
Constitutional and environmental factors related to serum lipid and lipoprotein levels. Ann Intern Med (1967) 1.36
Single vertical spin density gradient ultracentrifugation. Methods Enzymol (1986) 1.36
Studies on the major sialoglycoprotein of the human red cell membrane. Isolation and characterization of tryptic glycopeptides. Biochemistry (1973) 1.35
Aortic root dilatation at sinuses of valsalva and aortic regurgitation in hypertensive and normotensive subjects: The Hypertension Genetic Epidemiology Network Study . Hypertension (2001) 1.29
Diagnoses, symptoms, and attribution of symptoms among black and white inpatients admitted for coronary heart disease. Am J Public Health (1994) 1.28
Structural studies of apolipoprotein A-I/phosphatidylcholine recombinants by high-field proton NMR, nondenaturing gradient gel electrophoresis, and electron microscopy. Biochemistry (1984) 1.27
Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J Clin Invest (1994) 1.26
Dietary therapy slows the return of hypertension after stopping prolonged medication. JAMA (1985) 1.26
Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry (1995) 1.25
Quantification of cholesterol in all lipoprotein classes by the VAP-II method. J Lipid Res (1994) 1.25
Sibling correlation of left ventricular mass and geometry in hypertensive African Americans and whites: the HyperGEN study. Hypertension Genetic Epidemiology Network. Am J Hypertens (2001) 1.24
Possible locus on chromosome 18q influencing postural systolic blood pressure changes. Hypertension (2000) 1.24
Single-unit activity of cerebellar nuclear cells in the awake genetically dystonic rat. Neuroscience (1998) 1.24
George C. Griffith lecture. An appraisal of coronary bypass grafting. Circulation (1974) 1.22
Molecular basis for prokaryotic specificity of magainin-induced lysis. Biochemistry (1995) 1.21
Trends in systolic blood pressure in the thousand aviator cohort over a twenty-four-year period. Circulation (1967) 1.21
Molecular features of the major glycoprotein of the human erythrocyte membrane. Fed Proc (1973) 1.20
Turnover of synthetic class A amphipathic peptide analogues of exchangeable apolipoproteins in rats. Correlation with physical properties. Arterioscler Thromb (1992) 1.19
Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA study. Arteriosclerosis (1990) 1.19
Apolipoprotein-mediated plasma membrane microsolubilization. Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid. J Biol Chem (1999) 1.19
Effect of end group blockage on the properties of a class A amphipathic helical peptide. Proteins (1993) 1.19
The Hypertension Prevention Trial: assessment of the quality of blood pressure measurements. Am J Epidemiol (1991) 1.18
A comparative study of glycopeptides derived from selected vertebrate collagens. A possible role of the carbohydrate in fibril formation. J Biol Chem (1970) 1.16
Amyloid A: amphipathic helixes and lipid binding. Biochemistry (1976) 1.15
Amphipathic helixes and plasma lipoproteins: thermodynamic and geometric considerations. Chem Phys Lipids (1977) 1.15
Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. J Am Coll Cardiol (1985) 1.15
Genome-wide linkage analysis of lipids in the Hypertension Genetic Epidemiology Network (HyperGEN) Blood Pressure Study. Arterioscler Thromb Vasc Biol (2001) 1.13
Studies of synthetic peptide analogs of the amphipathic helix. Correlation of structure with function. J Biol Chem (1985) 1.13
Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation. J Clin Invest (1990) 1.13
Physical activity in young black and white women. The CARDIA Study. Ann Epidemiol (1993) 1.11
Osmotically induced membrane tension modulates membrane permeabilization by class L amphipathic helical peptides: nucleation model of defect formation. Biophys J (2001) 1.10
Studies of synthetic peptide analogs of the amphipathic helix. Effect of charged amino acid residue topography on lipid affinity. J Biol Chem (1980) 1.10
High-density lipoprotein recombinants: evidence for a bicycle tire micelle structure obtained by neutron scattering and electron microscopy. FEBS Lett (1979) 1.09
Exercise blood pressure response and 5-year risk of elevated blood pressure in a cohort of young adults: the CARDIA study. Am J Hypertens (1994) 1.09
Analysis of epidemiologic studies of physical inactivity as risk factor for coronary artery disease. Prog Cardiovasc Dis (1972) 1.08
The isolation of identical hydroxylysyl glycosides from hydrolysates of soluble collagen and from human urine. J Biol Chem (1967) 1.08
Association between the alpha-adducin gene and hypertension in the HyperGEN Study. Am J Hypertens (2000) 1.07
Sex-specific findings from a genome-wide linkage analysis of human fatness in non-Hispanic whites and African Americans: the HyperGEN study. Int J Obes (Lond) (2005) 1.06
Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic alpha-helixes. Biochemistry (1998) 1.06
Variations in human urinary O-hydroxylysyl glycoside levels and their relationship to collagen metabolism. J Clin Invest (1970) 1.05
The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein. J Biol Chem (1994) 1.05
Electrocardiographic findings in a biracial, urban population. The Birmingham Stroke Study. Ala J Med Sci (1973) 1.04
Recent status of detection, treatment, and control of hypertension in the community. J Community Health (1979) 1.04
Research related to surgical treatment of coronary artery disease. Circulation (1979) 1.02
Antiviral effects of apolipoprotein A-I and its synthetic amphipathic peptide analogs. Virology (1990) 1.02
Minimal size phosphatidylcholine vesicles: effects of radius of curvature on head group packing and conformation. Biochemistry (1982) 1.01
Rechallenge with crystalline niacin after drug-induced hepatitis from sustained-release niacin. JAMA (1990) 1.01
Surgical versus medical treatment of occlusive disease confined to the left anterior descending coronary artery. Am J Cardiol (1975) 1.01
Long-term results of the medical treatment of coronary artery disease. Angiology (1977) 1.00
Amphipathic helixes and plasma lipoproteins: a computer study. Biopolymers (1977) 1.00
Characterization of high density lipoprotein subspecies: structural studies by single vertical spin ultracentrifugation and immunoaffinity chromatography. J Lipid Res (1987) 0.99
Trials of hypertension prevention. Phase I design. Ann Epidemiol (1991) 0.99
Hyperlipidemia: diagnostic and therapeutic perspectives. J Clin Endocrinol Metab (2000) 0.98
Left ventricular systolic dysfunction in a biracial sample of hypertensive adults: The Hypertension Genetic Epidemiology Network (HyperGEN) Study. Hypertension (2001) 0.98
Relation of various degrees of body mass index in patients with systemic hypertension to left ventricular mass, cardiac output, and peripheral resistance (The Hypertension Genetic Epidemiology Network Study). Am J Cardiol (2001) 0.98
Black-white comparison of indices of coronary heart disease and myocardial infarction in the stepped-care cohort of the Hypertension Detection and Follow-Up Program. Am Heart J (1984) 0.98
Identification and cholesterol quantification of low density lipoprotein subclasses in young adults by VAP-II methodology. J Lipid Res (1995) 0.97
Changes in working status of patients following coronary bypass surgery. JAMA (1977) 0.97